COI Pharmaceuticals

COI Pharmaceuticals is a biotechnology startup focused on providing life science inventors with an environment where entrepreneurial and scientific risks are encouraged and rewarded. Established in 2013, the company operates with the slogan "Community. Opportunity. Innovation." The core objective of COI Pharmaceuticals, also known as COI=Community of Innovation, is to empower life science inventors by offering a fully-equipped R&D infrastructure and industry mentors to help them succeed. By eliminating operational distractions, the company enables scientists to concentrate on driving big ideas forward.

COI Pharmaceuticals is the brainchild of Avalon Ventures, aiming to apply their proven portfolio strategy for launching disruptive drug discovery, technology platforms, and healthcare IT companies in new market areas. Their approach is based on a unique capital structure, real-time decision-making, and the startup wisdom of seasoned serial entrepreneurs who act as venture partners. This approach provides ongoing support and guidance as the portfolio companies grow and increase in value.

As a player in the biotechnology industry, COI Pharmaceuticals stands out for its commitment to fostering entrepreneurial and scientific innovation, creating a conducive environment for scientists to make significant discoveries and breakthroughs.